ALKEM

Alkem Laboratories Share Price

 

 

Invest in Alkem Laboratories with 3.77X leverage

Invest with MTF

Performance

  • Low
  • ₹5,745
  • High
  • ₹5,915
  • 52 Week Low
  • ₹4,492
  • 52 Week High
  • ₹5,934
  • Open Price₹5,840
  • Previous Close₹5,812
  • Volume78,718
  • 50 DMA₹5,675.68
  • 100 DMA₹5,587.95
  • 200 DMA₹5,453.28

Investment Returns

  • Over 1 Month + 1.57%
  • Over 3 Month + 3.71%
  • Over 6 Month + 23.64%
  • Over 1 Year + 22.69%

Smart Investing Starts Here Start SIP with Alkem Laboratories for Steady Growth!

Invest Now

Alkem Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.8
  • PEG Ratio
  • 2.7
  • Market Cap Cr
  • 70,424
  • P/B Ratio
  • 5.3
  • Average True Range
  • 133.7
  • EPS
  • 196.58
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 9.52
  • RSI
  • 63.16
  • MFI
  • 45.86

Alkem Laboratories Financials

Alkem Laboratories Technicals

EMA & SMA

Current Price
₹5,890.00
+ 78.5 (1.35%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹5,717.03
  • 50 Day
  • ₹5,675.68
  • 100 Day
  • ₹5,587.95
  • 200 Day
  • ₹5,453.28

Resistance and Support

5850 Pivot Speed
  • R3 6,125.00
  • R2 6,020.00
  • R1 5,955.00
  • S1 5,785.00
  • S2 5,680.00
  • S3 5,615.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alkem Laboratories Ltd, is one of India’s largest pharmaceutical companies, known for its leading brands like Clavam and Pan-D. With 21 manufacturing facilities and global presence in over 50 countries, Alkem drives innovation with 500+ scientists across 5 R&D centers.

Alkem Laboratories has an operating revenue of Rs. 13,890.16 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 19% is great, ROE of 18% is exceptional. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alkem Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results & Interim Dividend
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results
2025-05-29 Audited Results & Final Dividend
2025-02-07 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-08-08 FINAL Rs.8.00 per share(400%)Final Dividend
2025-02-14 INTERIM Rs.37.00 per share(1850%)Interim Dividend
2024-08-10 FINAL Rs.5.00 per share(250%)Final Dividend
2024-02-17 INTERIM Rs.35.00 per share(1750%)Interim Dividend
2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
View Alkem Laboratories Dividend History Arrow

Alkem Laboratories F&O

Alkem Laboratories Shareholding Pattern

51.2%
16.06%
3.96%
9.97%
0%
17.09%
1.72%

About Alkem Laboratories

  • NSE Symbol
  • ALKEM
  • BSE Symbol
  • 539523
  • Managing Director
  • Mr. Sandeep Singh
  • ISIN
  • INE540L01014

Similar Stocks to Alkem Laboratories

Alkem Laboratories FAQs

Alkem Laboratories share price is ₹5,890 As on 12 February, 2026 | 04:13

The Market Cap of Alkem Laboratories is ₹70423.8 Cr As on 12 February, 2026 | 04:13

The P/E ratio of Alkem Laboratories is 29.8 As on 12 February, 2026 | 04:13

The PB ratio of Alkem Laboratories is 5.3 As on 12 February, 2026 | 04:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23